ARKG opened the position from scratch. The rest of the day's trades, plus ARK's scorecard against the S&P 500.

Generated from ARK's own holdings data.
ARKG bought an estimated $20.5M of Iambic Therapeutics Inc (IAM) on 20 Oct 2026. Yesterday the position was zero.
This isn't a one-off. Across 1 trades in 30 days, ARK has bought a net $20.5M of the stock.
ARK made 8 real moves that day, once money flowing in and out of the funds is stripped out:
| Stock | Funds | Est. value |
|---|---|---|
| IAM Iambic Therapeutics IncNew position | ARKG | +$20.5M |
| CRWV CoreWeave Inc | ARKK | +$8.9M |
| PSNL Personalis IncSold 10 days running | ARKG | −$4.5M |
| PLTR Palantir Technologies Inc | ARKK | −$3.1M |
| SHOP Shopify Inc | ARKK | −$3.1M |
| NTLA Intellia Therapeutics Inc | ARKG and ARKK | +$1.4M |
Zoom out to 30 days and ARK's largest net purchases are Nvidia Corp ($81.0M), CoreWeave Inc ($74.9M), Rocket Lab ($51.6M). On the other side, it has been cutting Advanced Micro Devices ($126.3M), Personalis Inc ($83.5M), 10X Genomics Inc ($76.2M).
So far this year ARKG is winning — +63.5% against the S&P 500's +13.3%.
ARKG has lagged the index by 9 points over the past month (-8.3% vs +0.6%). Most of the damage came from Tempus AI Inc (-20%, 9% of the fund), Genedx Holdings Corp (-37%, 3% of the fund), Twist Bioscience Corp (-10%, 9% of the fund).
Over the past year the gap is wider: ARKG returned +52.8% against +16.6% for the S&P 500, 36 points apart.
Over five years the gap is 119 points. ARKG is 58% below its all-time high from Jan 2021, having fallen as much as 84% at its worst in Apr 2025.
| To date | 1 month | YTD | 1 year | 5 years |
|---|---|---|---|---|
| ARKG | -8.3% | +63.5% | +52.8% | -37.6% |
| S&P 500 (SPY) | +0.6% | +13.3% | +16.6% | +81.9% |
| Nasdaq-100 (QQQ) | -0.3% | +17.2% | +19.4% | +96.9% |
ETFpeek is an independent research tool and is not affiliated with ARK Invest or Cathie Wood. Figures are estimates from public fund data, shown for information only — not financial advice. Past performance does not indicate future results.